Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PLEASE keep posting so I can buy another million shares in the 3's...
Please don't stop!!
OWCP Long & Strong!
Super excited about the future of OWCP!
Scooped up a few more shares today! Thank you very much!
If this even sniffs at 3 cents I will buy another million shares for sure.
Its the final countdown!
GET READY!
Lots to look forward to here. The next leg up will be a substantial one.
OWC Pharmaceutical Research Corp. (OTCQB: OWCP), ("OWC") and STENOCARE A/S ("STENOCARE") have signed a strategic Memorandum of Understanding (MoU) to develop and commercialize new cannabis-based medical products.
OWC has performed pre-clinical studies and has completed a human safety study with a cannabis-based ointment and is in the process of procuring the necessary permits for an efficacy study on psoriatic patients.
This allowed US patent application adds significantly to OWC's intellectual property portfolio, which includes issued patents for treatment of skin conditions in the Czech Republic and Australia, as well as other families of patent applications currently under prosecution, directed to the use of cannabis-based extracts for further clinical indications and various non-clinical applications. OWC believes that this topical ointment could offer relief for patients suffering from conditions such as Psoriatic lesions of the face, which currently lack effective alternative topical treatments.
"OWC has been working diligently to establish itself as a differentiated cannabis company, based on quality clinical development and the prosecution of its intellectual property portfolio. This patent allowance, in the United States, constitutes a significant milestone in the validation of our business strategy in a key product area," stated Mr. Mordechai Bignitz, the CEO of OWC.
The ointment aimed to treat a variety of skin conditions using a CBD and THC extracts. After Phase 1 trials lasting over a year, OWC reported positive results, implying that the firm will embark on Phase 2.
Phase 1 successful
According to OWC, the Phase 1 trial opened in September 2017 with safety and tolerability as primary endpoints. The trial design utilized placebo as control. The firm tested a 3% CBD and 3% THC regimen on healthy patients who responded positively. Researchers did not report any adverse events which would signify unacceptable levels of toxicity.
Phase 1 progressed in two stages where Stage I focused on single dose application. Here, healthy subjects applied a single dose of the ointment and observed for adverse events. Stage II involved repeated application of the ointment for six weeks. The primary endpoint was to evaluate the tolerability and safety of repeated application. Only one patient in Stage II reported minor irritation after applying the ointment.
Commenting on the developments, Mordechai Bignitz, OWC CEO termed the results quite encouraging. He said, “This was the first trial to assess the safety and tolerability of medical grade cannabis ointment as a topical treatment for skin diseases. We plan to commence a Phase 2 trial with MSC ointment for the treatment of psoriasis in the third quarter 2019.”
Interestingly, observers see the product development as strategic in terms of market position. Just last year, Canada legalized marijuana for recreational as well as medical use. Similarly, a few U.S. states allowed use of the products restrictively. All this put together, it represents a huge market for legal cannabis products.
However, the cannabis-derived drug segment is one that presents significant growth opportunities. First, the niche has little competition while demand is rising. In addition to the ointment, OWC has a pain-relieving soluble tablet as well in the pipeline.
The OWC multiple myeloma study was done by three repetitive tests on the effect of cannabis extract with various combination ratios of THC/CBD and pure THC and CBD (50% concentration). The results present more than 60% malignant cell death. More results of pure THC and CBD are under further analysis.
Multiple myeloma cells were cultured for 48 hours with CBD and THC (all cannabis extracts) as compare to their combinations - CBD: THC 1:1; CBD: THC 5:1 and CBD: THC 1:5. Combination Index (CI) value <1, =1, >1 indicates synergism, additive effect, and antagonism, respectively. Each treatment was performed in triplicate in four independent experiments and presented as mean. The treatment of CBD in combination with THC had synergistic effect, being their cytotoxic effect is higher with each of the three combinations tested.
CBD and THC decreased survival of multiple myeloma cells in a concentration-dependent manner.
Multiple myeloma, a cancer of plasma cells in the bone marrow, accounts for 10% of all hematologic malignancies. It is the second most common hematologic cancer and represents 1% of all cancer diagnoses and 2% of all cancer deaths.
The basic science phase of the study has begun several weeks ago, at the Sheba Academic Medical Center (affiliated with Tel-Aviv University). Dr. Merav Leiba, Head of Sheba's Multiple Myeloma Service and Multiple Myeloma Research Lab is leading the study. The company conducts the study in accordance with Sheba's Internal Review Board (IRB) approval.
Monday Madness!
OWCP will explode MONDAY!
You have it backwards.
It’s $100.00
OWCP is going to EXPLODE!
1.00, 3.00 ,5.00, 50.00 ZZZZZZZ
Back up the truck its time to load this puppy
OWC Israel's Patent for Cannabis Based Extracts and Topical Formulations for Use in Skin Disorders, Is Allowed for Issuance as a Patent in the USA.
Up over 1000% since 0.005
Quite obvious where this is headed
Position yourself now
Have no fear OWCP is here!
And here to stay...
For those of you that bought in the dollars now is a SICK time to average down. Are you kidding me?? 5 cents??? Dream price for what OWCP is. Clearly up over 1000% since 0.005. Numbers don't lie my friends. Live for tomorrow not yesterday!
OWCP is about to run HUGE!
100% probably sooner
OWCP is the future
Won't take much to push this over the edge
We are up over 1000% since 0.005
Strong base formed
Green Thurs Green Fri
Have no fear LOKELO is here!
OWCP is on the verge of some spectacular!
This has the making of potentially becoming a $50 stock.
OWCP up over 1000% since 0.005
GREEN DAY
Break out day just around the corner
Strong base. Up we go!
The next green day will be a HUGE day!
Breakout coming!
Late to the game??
Haha! OWCP invented the game my friends!
Patent in place!
Products consumer ready!
Up over 1000% since 0.005
OWC Pharmaceutical Cannabis Ointment Set To Proceed To PII After Positive PI Data.
Beautiful building in Ramat Gan Israel.
OWCP is the future my friends!
We will be GREEN TODAY!
LONG AND STRONG!
#OWCP
We will close GREEN!
OWCP power!
#HOMERUNCITY
Absolutely agree!